Lee Willis C

Vice Chairman & COO, DirectorEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4 · filed Feb 28, 2022
Net Buying
Open-Market Buys
$31K
Open-Market Sells
$0
Net Open-Market Flow
$31K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 28, 2022Buy(P)900$1.65$1K2K
Feb 28, 2022Buy(P)7K$1.50$10K235K
Feb 28, 2022Buy(P)7K$1.51$11K270K
Feb 24, 2022Buy(P)6K$1.44$8K263K
Feb 22, 2022Buy(P)500$1.42$710257K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-013725) within minutes of acceptance. Every field above traces to the original document. Verify it directly: